Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length
about
Transglutaminases: nature's biological gluesIdentification of tissue transglutaminase-reactive lysine residues in glyceraldehyde-3-phosphate dehydrogenaseThe alpha-ketoglutarate dehydrogenase complexStructural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeatsReduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts.Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability.Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases.Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDHCerebrometabolic abnormalities in Alzheimer's disease.Experimental therapeutics in transgenic mouse models of Huntington's disease.Novel Metabolic Abnormalities in the Tricarboxylic Acid Cycle in Peripheral Cells From Huntington's Disease Patientsγ-Glutamylamines and neurodegenerative diseasesTransglutaminase activity is present in highly purified nonsynaptosomal mouse brain and liver mitochondria.Induction of chondrogenic differentiation in mesenchymal stem cells by TGF-beta cross-linked to collagen-PLLA [poly(L-lactic acid)] scaffold by transglutaminase 2.Transglutaminase activation in neurodegenerative diseases.Transglutaminases and neurodegeneration.Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases.Role of tissue transglutaminase-2 (TG2)-mediated aminylation in biological processes.Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways.Factors Affecting Aggregate Formation in Cell Models of Huntington's Disease and Amyotrophic Lateral Sclerosis.Déjà vu with a twist: transglutaminases in bioenergetics and transcriptional dysfunction in Huntington's disease.BMP2 cross-linked by transglutaminase 2 to collagen-plla scaffold promotes osteogenic differentiation in mesenchymal stem cellsCisplatin-induced toxicity is associated with platinum deposition in mouse kidney mitochondria in vivo and with selective inactivation of the alpha-ketoglutarate dehydrogenase complex in LLC-PK1 cells.N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease.Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family.Brain Energy and Oxygen Metabolism: Emerging Role in Normal Function and Disease.Inhibition of α-ketoglutarate-and pyruvate dehydrogenase complexes in E. coli by a glutathione S-transferase containing a pathological length poly-Q domain: A possible role of energy deficit in neurological diseases associated with poly-Q expansions
P2860
Q24534936-41F1A2C7-F2A9-45D6-9650-9AA50400704AQ28366199-9E36B36D-93BC-4C6A-95FC-939AB0D2397AQ28609410-94846417-EEA0-4882-9AFF-DD98711D7ADAQ31122113-ADC8C8F2-21BA-407D-B811-7248F5673180Q32034809-3D2CF135-8653-4365-BE2D-03170DF5A4F1Q33536410-A6A94F73-4AD5-4659-BE9A-CE7EAF559971Q33926887-19B50D02-F875-4C95-B9D2-752CA0519AC6Q34480379-2F9BFC79-5F05-4570-A30F-4322F63E8F0BQ35540355-E705DF4E-A760-4F1D-97D3-D462656E9102Q35752429-F1CB2260-0CFE-4BA8-9A24-31EEAE5ACE62Q36127832-E75F4CB4-026F-46A0-A16E-528D00B44A07Q36377238-458BA854-D4B9-414A-83CE-778830D62A60Q37001587-C7EF48B5-4788-4CA1-A698-C6EB0EFBF70CQ37296940-6F56827E-1DA1-4229-A1AB-6C3551F15F7DQ37352964-05E16A61-7AD5-40BA-95F0-5DBDA2DFECC9Q37365083-812B68EB-7CD6-4732-82A6-20C35D0158D6Q37466088-14D8E907-35A9-4498-AE29-19BC35DD971FQ38857583-A0FF4343-D11A-4CC2-8E80-41F9CE4148F7Q39029196-3FD586C1-F6A2-46DA-B4FA-941D8D4D6CF1Q41522392-CF3DE66C-F720-4D4D-A9CA-0EFBCB162413Q42204907-B564A736-AE1C-4803-B97C-98109E434278Q42543526-26B2C9A5-DA35-45F7-B813-B26D347A3CC8Q42791128-BFACF561-307A-480C-8309-AD61AFA4D3E9Q43820046-77F4BF89-4224-441E-B2C0-9F761CC3C550Q55499802-2BF8E758-FB63-4EFB-ADDC-EDE4E9598465Q55514851-D98C1CED-0555-4FA1-BF47-1D88373C606EQ57417893-74D5FCE7-75FF-4C86-85AC-D4339A5D8315
P2860
Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Transglutaminase-catalyzed ina ...... domains of pathological length
@en
type
label
Transglutaminase-catalyzed ina ...... domains of pathological length
@en
prefLabel
Transglutaminase-catalyzed ina ...... domains of pathological length
@en
P2093
P2860
P356
P1476
Transglutaminase-catalyzed ina ...... domains of pathological length
@en
P2093
A J Cooper
W J Strittmatter
P2860
P304
12604-12609
P356
10.1073/PNAS.94.23.12604
P407
P577
1997-11-01T00:00:00Z